In today’s recent session, 3.01 million shares of the Lantern Pharma Inc (NASDAQ:LTRN) have been traded, and its beta is 1.56. Most recently the company’s share price was $3.62, and it changed around $0.47 or 14.92% from the last close, which brings the market valuation of the company to $39.04M. LTRN at last check was trading at a discount to its 52-week high of $6.12, offering almost -69.06% off that amount. The share price’s 52-week low was $2.55, which indicates that the recent value has risen by an impressive 29.56% since then. We note from Lantern Pharma Inc’s average daily trading volume that its 10-day average is 64670.0 shares, with the 3-month average coming to 58.10K.
Lantern Pharma Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended LTRN as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Lantern Pharma Inc is expected to report earnings per share of -0.49 for the current quarter.
Lantern Pharma Inc (NASDAQ:LTRN) trade information
Instantly LTRN has been showing a green trend so far today with a performance of 14.92% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.73 on recent trading dayincreased the stock’s daily price by 2.95%. The company’s shares are currently down -15.62% year-to-date, but still up 14.56% over the last five days. On the other hand, Lantern Pharma Inc (NASDAQ:LTRN) is 5.54% up in the 30-day period. We can see from the shorts that 0.28 million shares have been sold at a short interest cover period of 3.77 day(s).
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -37.87%. Lantern Pharma Inc earnings are expected to increase by 4.66% in 2025, but the outlook is negative -2.53% per year for the next five years.
LTRN Dividends
Lantern Pharma Inc’s next quarterly earnings report is expected to be released on 2025-May-15.
Lantern Pharma Inc (NASDAQ:LTRN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 14.10% of Lantern Pharma Inc shares, and 21.49% of them are in the hands of institutional investors. The stock currently has a share float of 25.01%. Lantern Pharma Inc stock is held by 38.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.3807% of the shares, which is about 0.36 million shares worth $1.7 million.
NEWEDGE ADVISORS, LLC, with 1.4604% or 0.16 million shares worth $0.73 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 256.11 shares worth $0.95 million, making up 2.37% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 99.27 shares worth around $0.37 million, which represents about 0.92% of the total shares outstanding.
